📑MATERIAS PRIMAS PARA LABORATORIO FARMACÉUTICO
Procurement process summary
This process is to purchase Materias primas para laboratorio farmacéutico.
This contract was awarded by 🇺🇾 Dirección Nacional de Sanidad de las Fuerzas Armadas for an amount of UYU 583,855 to 1 supplier. It was published on 2025-10-16 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 Dirección Nacional de Sanidad de las Fuerzas Armadas Buying unitnot reported Publication date2025-10-16 Contest statusnot reported DescriptionCompra Directa 397/2025Awards
This award was granted to ENOL S.A. by Dirección Nacional de Sanidad de las Fuerzas Armadas for an amount of UYU 583,855. The procurement process was conducted through open for the category of Not available. The award was granted on 2025-09-11.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 ENOL S.A. | UYU 583,855 | 2025-09-11 |
Market context and opportunities
The execution of this contract allows the entity Dirección Nacional de Sanidad de las Fuerzas Armadas to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-1249825-R211505770014Publication date2025-10-16Contract datenot reportedAward date2025-09-11Categoriesnot reportedPurchase modalityopenMethod detailsCompra DirectaStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
